Latest news with #BainCapital-backed
Malaysian Reserve
04-07-2025
- Business
- Malaysian Reserve
Bridge Data Centres Unveils Inaugural ESG Report, Outlines Vision for a Sustainable Digital Future
Significant advances in innovative cooling technologies in past year lowered power usage effectiveness (PUE) in subtropical regions to below 1.2 Report details six environmental performance domains — water resources management, high-efficiency thermal management, energy system resilience, carbon footprint reduction, green technology R&D, and digital energy governance SINGAPORE, July 4, 2025 /PRNewswire/ — Bridge Data Centres, a Bain Capital-backed hyperscale data centre platform, has unveiled its inaugural environmental, social and governance (ESG) report, detailing its blueprint for a sustainable data centre future. The rapid growth of data centre development across the Asia-Pacific region has intensified demand for high-performance, secure, and globally accessible computing. As data volumes surge and complexity increases, expectations are rising — data centres must deliver greater efficiency and reliability while reducing their environmental impact. Bridge Data Centres (BDC) is addressing these evolving demands through sustainability-led innovation. The ESG report details how the company is investing in energy-efficient systems, accelerating its transition to renewable energy, enhancing supply chain performance, and committing to emissions reductions. Ahead of the report's release, BDC established a three-tier ESG governance framework comprising governance, management, and execution layers, with the Board of Directors providing top-level oversight. Eric Fan, Chairman of Bridge Data Centres ESG Committee, commented, 'This inaugural ESG report is a testament to our commitment to building a future that is sustainable, equitable, and resilient. It reflects our core belief that the long-term success of our company is inseparable from the health of our planet, the well-being of our communities, and the trust we earn from our stakeholders.' The report highlights several technological milestones across six environmental performance domains — water resources management, high-efficiency thermal management, energy system resilience, carbon foot print reduction, green technology R&D, and digital energy governance. Backed by 588 patents, BDC has made significant strides in water recycling and on-site treatment systems to improve Water Usage Effectiveness (WUE). Breakthroughs in cooling technologies have lowered Power Usage Effectiveness (PUE) in subtropical regions to below 1.2 — setting a new company milestone for energy efficiency. In Thailand, BDC's facility generated 511 MWh of renewable energy through rooftop solar panels. Additionally, innovations in construction technology have enabled a 30% reduction in construction cycles, accelerating customer deployment while reducing construction-related waste. Bridge Data Centres is now a member of RE100 and has committed to achieving 100% renewable energy usage by 2040. BDC has also submitted goals to Science-based Targets Initiative (SBTi). The ESG report also details BDC's social impact. Over the past year, BDC has increased employment by over 24% year-on-year, with 85% of new hires hired in local markets, generating localized job opportunities and contributing to talent development for the data centre sector. Women represented 33.3% of the BDC executive management team – a notable figure in the data centre industry. 'As a digital infrastructure designer and builder, we have a unique responsibility — and powerful opportunity — to lead the way in sustainability. The choices we make today in design, construction, and operations will shape the future of our environment and society,' added Mr Fan. Download the Bridge Data Centres inaugural ESG report here: About Bridge Data Centres Backed by global leading investment firm Bain Capital, Bridge Data Centres is a pan-Asian hyperscale data infrastructure builder, striving for an ever-growing and transforming digital future. We focus on empowering our clients and their cloud-first and AI-driven strategy, through our hyperscale, build-to-suit, and colocation data solutions.
&w=3840&q=100)
Business Standard
04-07-2025
- Business
- Business Standard
Emcure Pharma shares dip after 2.4% stake change hands in block trades
Shares of Emcure Pharmaceuticals fell over 2 per cent on Friday after about 4.53 million shares changed hands in block trades during market opening. The pharmaceutical company's stock fell as much as 2.33 per cent during the day to ₹1,250 per share, the biggest intraday fall since June 26 this year. The stock pared losses to trade 1.9 per cent lower at ₹1,255 apiece, compared to a 0.2 per cent decline in Nifty 50 as of 12:22 PM. Shares of the company have fallen 10 per cent from its recent highs of ₹1,403 apiece, which it hit in May. The stock currently trades at 41 times the average 30-day trading volume, according to Bloomberg. The counter has fallen 13.5 per cent this year, compared to a 7.5 per cent advance in the benchmark Nifty 50. Emcure Pharmaceuticals has a total market capitalisation of ₹23,862.89 crore. Emcure Pharma block trade The company's shares fell after about 4.53 million shares, or a 2.4 per cent stake, changed hands via block trades on the National Stock Exchange, according to Bloomberg data. Buyers and sellers were not known immediately. However, reports said that Bain Capital-backed BC Investments IV was looking to offload a 2.4 per cent stake in the pharma major for ₹551 crore. The floor price for the transaction was set at ₹1,279.80 per share, the reports added. As of BSE shareholding data, BC Investments IV had an 8.68 per cent stake in Emcure Pharmaceuticals as of the March 2025 quarter. Emcure Pharma Q4 results Emcure Pharmaceuticals posted a 63 per cent year-on-year (Y-o-Y) growth in its consolidated net profit at ₹197.2 crore for the March quarter of the financial year 2024–25 (Q4FY25), up from ₹121 crore in the same period last year. The company's revenue from operations rose to ₹2,116.2 crore, a 19.5 per cent increase from ₹1,771.3 crore in Q4FY24. Emcure's domestic business grew by 24.8 per cent Y-o-Y to ₹929 crore, led by growth in its women's health and cardiology franchises. 'It was further aided by our new focus areas of dermatology and over-the-counter (OTC),' the company said in a regulatory filing to the exchanges. About Emcure Pharmaceuticals Emcure Pharma has over 350 brands, five research and development (R&D) centres, and 13 manufacturing facilities established across the country. Outside India, it has a wide network across 70 countries. The company's API facilities ensure that the supply chain is vertically integrated, providing flexibility over control of manufacturing.
Mint
24-06-2025
- Business
- Mint
Virgin Australia Boss Brushes Off Mideast Fears as Shares Debut
(Bloomberg) -- Virgin Australia Holdings Ltd. Chief Executive Officer Dave Emerson brushed away concerns the Middle East conflict will disrupt demand for travel as the airline returned to the stock exchange in Sydney in a A$685 million ($440 million) initial public offering. After years of planning, the Bain Capital-backed carrier resumed trading on Tuesday. The first shares changed hands just hours after Iran's retaliatory missile attack on a US air base in Qatar, and an announcement by President Donald Trump that Israel and Iran had agreed to a tentative ceasefire. The stock jumped as much as 9.7% in the first minutes of trading. The US buyout firm sold 30% of Virgin Australia for A$2.90 a share. While Virgin Australia generates most of its profit from the Australian market, the company has significant ties to the Gulf region. Qatar Airways owns about 25% of the airline, and Virgin Australia operates long-haul flights to Doha from Australian cities using aircraft leased from Qatar Airways. Some of those services were diverted following the temporary closure of Qatar airspace. In an interview on Monday, Emerson was pragmatic about the timing of the long-awaited IPO, which exposes Virgin Australia to broader market turmoil and coincided with the biggest upheavals in the Middle East in years. 'That's aviation,' Emerson said. But he said Virgin Australia is largely insulated from the region. 'Our expectation is that the Australian domestic market will continue to be relatively unaffected and that demand will remain strong,' Emerson said. 'The Australia domestic market has been incredibly resilient historically to these global geopolitical shocks.' Virgin Australia was founded as a budget carrier in 2000 with start-up capital from Richard Branson. It later moved away from a low-cost model in an ill-fated attempt to compete head-on with Qantas Airways Ltd. Saddled with debt, Virgin Australia became the first high-profile airline casualty of the pandemic when it collapsed in 2020. Bain Capital bought the business the same year and has transformed the company. With a simpler fleet, reduced costs and less debt, Virgin Australia has now strung together consecutive annual profits. The IPO ensures an even sweeter payout for the buyout firm after its bold bet on the defunct airline. Bain Capital paid about A$730 million for Virgin Australia's equity five years ago. Since then, the firm has recouped more than A$1 billion in capital returns and dividends, according to the listing prospectus, in addition to the stake sale to Qatar Airways. Bain still owns around 40% of Virgin Australia. Middle East tensions aside, Virgin Australia is listing at a favorable moment that won't last forever, some analysts argue. The limited supply of aircraft globally since Covid-19 has led to fuller planes and higher ticket prices. At the same time, the recent collapses of smaller Australian airlines Rex and Bonza have reduced competition. The same conditions have sent the share price of Qantas soaring to a record. Emerson says there's more growth to come. 'I don't see the market as having peaked,' he said. And he doesn't expect an imminent solution to the shortage of aircraft. 'That's likely to continue for three to five years,' he said. 'The ability of the manufacturers to scale up remains very constrained.' The lack of new jets also makes it tougher for rival airlines to enter the Australian market, he said. 'It's a great time to be an almost wholly Australian-focused airline,' he said. More stories like this are available on
Business Times
19-06-2025
- Business
- Business Times
Blackstone's ASK plans to hire 70 wealth bankers in India
[MUMBAI] Blackstone's ASK Group plans to hire 70 private bankers as competition heats up within India's booming wealth management space. ASK's private wealth unit aims to have 175 bankers by the end of March next year, up from about 105 now, Rajesh Saluja, chief executive officer and co-founder of the business, said. The rise of wealthy Indians across the country has sparked the creation of many new firms competing to manage their money, while more established players like ASK Private Wealth, Bain Capital-backed 360 One WAM and PAG-backed Nuvama Wealth Management are expanding their teams. Mumbai-based ASK Private Wealth has 520 billion rupees (S$7.7 billion) of assets under advisory for more than 3,700 families. Blackstone acquired a majority stake in the broader ASK Group in 2022. The group has over 745 billion rupees in assets across alternative investment funds, portfolio management services and private wealth. Even with the growth, ASK will be cautious about hiring, especially those private bankers who have been jumping jobs often or who see risky products as their ticket to personal wealth creation, Saluja said. 'I want to be sure that the expense is justified, they fit our culture, and we are getting the right candidate,' he said. Saluja expects investors to continue investing in gold and fixed-income alternative funds such as distressed and high-yield debt, while remaining committed to equity index funds and mutual funds, among other asset classes. BLOOMBERG
Mint
13-06-2025
- Business
- Mint
Bain Capital-backed CitiusTech exploring acquisitions, to evaluate IPO
Bain Capital-backed CitiusTech, a healthcare technology services company, is planning to grow through acquisitions and will evaluate an IPO this year, either in the US or India, chief executive officer (CEO) Rajan Kohli told Mint in an interview. 'It is very much in our growth path," Kohli said, referring to the company's plan to list on the exchanges. 'We will evaluate [it] this year if the markets are good," he said, adding that the company will evaluate listing in either India or the US. The firm's primary market is the US, accounting for 95% of its revenues. Its investors are Bain Capital Private Equity and EQT Private Capital Asia (previously Baring Private Equity Asia). Also read: FPI Tracker: Telecom, services, capital goods corner major chunk of inflows; IT, healthcare face heavy selling in May In 2022, Bloomberg reported, citing people in the know, that CitiusTech had filed confidentially for a US IPO. The health tech firm is planning expansions in Europe and Japan, as demand for healthcare technology services increases among medtech, healthcare, and life sciences companies. Kohli said that the firm's specialised focus on healthcare gives it an edge over large Indian IT service companies that cater to various industries. A few other Indian companies are focused solely on healthcare tech services, like IKS Health, which was listed on the exchanges in December 2024 and posted ₹2,664 crore revenue in FY25. Acquisitions drive growth The firm is looking at acquisitions this year to drive growth. 'We didn't make any acquisitions for the last two years because the valuation was not great in the market," Kohli said, adding that this year the company is targeting two acquisitions, provided it finds targets that meet its requirements. CitiusTech is exploring acquisition options which would strengthen its foray into Europe as well as enhance its abilities in the healthcare provider market. Also read: Jainik Power and Cables IPO allotment to be out soon: Here are steps to check status online and GMP The company had previously stated a target of $1 billion in revenue by FY28, which it is still aiming for, Kohli said. 'On an organic basis, we continue to grow as per plan," he said. The company is expecting mid-teens revenue growth in FY26, after high single-digit revenue growth in FY25, Kohli said. While it hasn't yet posted its FY25 results, it clocked revenue of ₹3,536 crore and a profit of ₹350 crore in FY24. GenAI tailwind Kohli sees GenAI as a significant tailwind driving growth, as companies look for cost optimisation solutions. '...today, 25% of our clients give us the opportunity to use GenAI tools. I think in one or two years, 80-100% of our clients will allow GenAI-produced code into their environment," he said. Also read: Aten Papers & Foam IPO Day 1: Check subscription status, GMP, and other details Being a healthcare-focused service provider gives CitiusTech an edge as well, according to Kohli. 'It is a huge advantage being just focused on healthcare because a lot of our clients buy us because of our specialised capabilities. All our investment, all our R&D, all our training goes into healthcare only," he said.
